Niresh Maheshwari
Directeur/Membre du Conseil chez Cubic Capital Advisors LLP
Profil
Niresh Maheshwari is an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
He is also a Director at Cubic Capital Advisors LLP and a Member of The Institute of Chartered Accountants of India.
Previously, he served as an Independent Non-Executive Director at Sobhagya Mercantile Ltd.
from 2022 to 2024 and as the Chief Financial Officer at Uniinfo Telecom Services Ltd.
from 2018 to 2020.
He completed his undergraduate and graduate degrees from Devi Ahilya University.
Postes actifs de Niresh Maheshwari
| Sociétés | Poste | Début |
|---|---|---|
| The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Directeur/Membre du Conseil | 20/09/2018 |
| Cubic Capital Advisors LLP | Directeur/Membre du Conseil | - |
Anciens postes connus de Niresh Maheshwari
| Sociétés | Poste | Fin |
|---|---|---|
| SOBHAGYA MERCANTILE LIMITED | Directeur/Membre du Conseil | 07/06/2024 |
| UNIINFO TELECOM SERVICES LIMITED | Directeur Financier/CFO | 30/06/2020 |
Formation de Niresh Maheshwari
| Devi Ahilya University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOBHAGYA MERCANTILE LIMITED | Non-Energy Minerals |
| UNIINFO TELECOM SERVICES LIMITED | Communications |
| Entreprise privées | 2 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
| Cubic Capital Advisors LLP |
